Provider-prescribed weight loss programs utilizing semaglutide-based therapy — supervised by our physician with comprehensive metabolic monitoring.
Semaglutide is a GLP-1 receptor agonist that works by supporting the body's natural appetite-regulating mechanisms. It is the active pharmaceutical ingredient (API) found in branded medications including Ozempic and Wegovy, which are FDA-approved products.
At DuPage Medical Wellness, our weight loss programs may utilize medications prescribed based on individual patient needs. Your provider will determine the most appropriate treatment plan following a comprehensive clinical evaluation. Compounded formulations are not FDA-approved.
Published research on the FDA-approved branded medication Wegovy (semaglutide 2.4mg) demonstrated significant weight loss outcomes in clinical trial participants. These results apply to the studied branded formulation and may not apply to compounded versions.
Read the Published StudyMeet with our physician to review your health history, goals, and candidacy for treatment
Comprehensive blood panel and metabolic review before any prescription is issued
If indicated, start your prescribed program with a personalized titration schedule
Progress check-ins with 3D body scan and medication adjustments as needed
In-clinic in Naperville or via telehealth.
Or call us at 630-857-9333
